Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’snews2026-01-12T11:56:20+00:00January 12th, 2026|Endpoints News|
Kinaset rakes in $103M to advance inhaled asthma drugnews2026-01-12T11:49:32+00:00January 12th, 2026|Endpoints News|
Signal Pulse Poll: What’s the mood going into JPM?news2026-01-11T17:20:18+00:00January 11th, 2026|Endpoints News|
Private and public biotechs go on $4.9B funding spree ahead of JPMnews2026-01-11T14:00:31+00:00January 11th, 2026|Endpoints News|
Biotech’s 2026 outlook: Six questions for the year aheadnews2026-01-11T13:45:23+00:00January 11th, 2026|Endpoints News|
Mirador raises $250M, with plans to become an immunology powerhousenews2026-01-11T13:30:31+00:00January 11th, 2026|Endpoints News|
Genentech CEO says pharmacy benefit manager shift will save $70Mnews2026-01-11T13:00:10+00:00January 11th, 2026|Endpoints News|
Hair growth biotech Veradermics files for IPO to fund oral Rogainenews2026-01-10T18:07:44+00:00January 10th, 2026|Endpoints News|
US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and morenews2026-01-10T11:00:00+00:00January 10th, 2026|Endpoints News|
Eikon Therapeutics files for IPO, testing biotech rallynews2026-01-09T22:14:35+00:00January 9th, 2026|Endpoints News|
